MYGN — Myriad Genetics, Inc. stock price, charts and financials

QT39Myriad Genetics, Inc.

Myriad Genetics, Inc. (NASDAQ: MYGN) is a Healthcare company in the Medical - Diagnostics & Research industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
3.89
-0.25-6.04%
OverviewShort InterestFilings
MYGNQT39Myriad Genetics, Inc.·NASDAQ
3.89-6.04%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 18, 20264Statement of changes in beneficial ownership
Sep 17, 20263Initial statement of beneficial ownership
Sep 17, 20264Statement of changes in beneficial ownership
Sep 16, 20268-KCurrent report
Sep 08, 20264Statement of changes in beneficial ownership
Sep 04, 2026SC 13GBeneficial ownership statement (passive)
Aug 17, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Jul 31, 202610-QQuarterly report
Jul 30, 20268-KCurrent report
Jun 23, 20268-KCurrent report
Jun 23, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
#1 / 25 of 512
Page
▼
/ 21